Is ANG Lifesciences India a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that ANG Lifesciences India Ltd is a good quality company .

Is ANG Lifesciences India undervalued or overvalued?

The key valuation ratios of ANG Lifesciences India Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone .

What is ANG Lifesciences India share price return in the past 10 years?

Data is not available for this company

Is ANG Lifesciences India a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of ANG Lifesciences India Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the P/E ratio of ANG Lifesciences India?

The latest standalone P/E ratio of ANG Lifesciences India as of 17-Apr-2025 is 0.00.

What is the P/B ratio of ANG Lifesciences India?

The latest standalone P/B ratio of ANG Lifesciences India as of 17-Apr-2025 is 0.52.

What is the 52-week high and low of ANG Lifesciences India?

The 52-week high of ANG Lifesciences India is Rs. 62.75 and the 52-week low is Rs. 21.03.

ANG Lifesciences India Ltd - Stock Valuation and Financial Performance

Name: ANG Lifesciences India
Brand: ANG Lifesciences India

BSE: 540694 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

ANG Lifesciences Share Price

₹27.89 0.28 1.01%
as on 17-Apr'25 16:01

DeciZen - make an informed investing decision on ANG Lifesciences

Based on:

Data

M-Cap below 100cr DeciZen not available

ANG Lifesciences India stock performance -

₹27.89 -29.00-51.00% past year

PE Chart Key Ratios

Price Chart, Live Stock Chart, Technical Chart of

P/E Ratio (SA):

0.00

Market Cap:

36.1 Cr.

52-wk low:

52-wk high:

62.8

Related Stocks

Is ANG Lifesciences India Ltd an attractive stock to invest in?

10 Year X-Ray of ANG Lifesciences: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	15.2%	23.4%	29.7%	22.2%	23.7%	22.4%	19.9%	53.8%	9.2%	0.7%	-
Value Creation Index ⓘ	0.1	0.7	1.1	0.6	0.7	0.6	0.4	2.8	-0.3	-1.0	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	36.8	54.9	67.7	76	122	127	154	349	207	131	106
Sales YoY Gr.	-	49.1%	23.2%	12.4%	60.1%	4.2%	21.6%	126%	-40.6%	-36.5%	-
Adj EPS ⓘ	0.4	1.8	3.1	2.9	4.5	4.9	5.6	30.7	-0.3	-5.6	-9.2
YoY Gr.	-	309.1%	70.6%	-6.5%	57.1%	9.5%	13.2%	449.9%	-100.9%	NA	-
BVPS (₹) ⓘ	3.4	5.2	8.1	17.9	22.2	26.7	31.9	64.4	65.5	59	52.7
Adj Net Profit ⓘ	0.4	1.7	2.8	3.7	5.8	6.4	7.3	39.8	-0.4	-7.4	-12
Cash Flow from Ops. ⓘ	3.1	1.9	4.5	0.9	7.5	4.8	-11.2	27.4	26	-13.1	-
Debt/CF from Ops. ⓘ	3.8	7.3	3	21.2	2.9	4.3	-3.8	2.2	2	-4.3	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	15.2%	1.5%	-5.2%	-36.5%
Adj EPS ⓘ	-232.8%	-204.6%	-200.3%	NA
BVPSⓘ	37.4%	21.6%	22.7%	-9.9%
Share Price	-	11%	-52.1%	-50.6%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	13.9	42	46.1	24.3	22.5	20.2	19.1	63.8	-0.4	-9.1	-16.5
Op. Profit Mgn % ⓘ	8.5	8.6	10	9.9	10	10.4	9.9	18.9	5.9	7.4	2.3
Net Profit Mgn % ⓘ	1.1	3	4.2	4.9	4.8	5.1	4.7	11.4	-0.2	-5.6	-11.3
Debt to Equity ⓘ	3.8	2.8	1.8	0.8	0.8	0.6	1	0.7	0.6	0.7	-
Working Cap Days ⓘ	158	139	168	198	152	180	223	155	299	439	216
Cash Conv. Cycle ⓘ	20	14	28	51	56	72	65	36	98	133	39

Recent Performance Summary

Latest Financials - ANG Lifesciences India Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-9.2	-10.7
TTM Sales (₹ Cr.)	106	114
BVPS (₹.) ⓘ	52.7	50.6
Reserves (₹ Cr.) ⓘ	56	53
P/BV ⓘ	0.52	0.55
PE ⓘ	0.00	0.00

From the Market
52 Week Low / High (₹)	21.03 / 62.75
All Time Low / High (₹)	10.62 / 640.36
Market Cap (₹ Cr.)	36.1
Equity (₹ Cr.)	13.1
Face Value (₹)	10
Industry PE ⓘ	38.8

Quarterly Results

Standalone Basis

Consolidated Basis

	Mar'24	YoY Gr. Rt. %	Jun'24	YoY Gr. Rt. %	Sep'24	YoY Gr. Rt. %	Dec'24	YoY Gr. Rt. %
Sales (₹ Cr.)ⓘ	884	19.1	891	21.9	922	17.1	868	11
Adj EPS (₹) ⓘ	2.5	21.7	2.4	23.7	2.4	12.1	2.5	7.3
Op. Profit Mgn % ⓘ	27.93	100 bps	27.97	27 bps	27.33	-61 bps	26.98	-276 bps
Net Profit Mgn % ⓘ	16.66	34 bps	15.76	24 bps	16.18	20 bps	17.82	26 bps

Management X-Ray of ANG Lifesciences:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

44.88

* Pledged shares as % of Promoter's holding (%)

Valuation of ANG Lifesciences

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

No data found!

Key Ratios of ANG Lifesciences

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Price Chart, Live Stock Chart, Technical Chart of

Sales (Cr.)

Price Chart, Live Stock Chart, Technical Chart of

ROE (%)

Price Chart, Live Stock Chart, Technical Chart of

ROCE (%)

Price Chart, Live Stock Chart, Technical Chart of

Peer Comparison

Company Name	CMP(₹)	Change ₹(%)	Market Cap	Net Sales (₹ Cr.)	Latest EPS (₹)	Net Profit Margin %	Latest P/E	Latest P/BV
Alembic Pharma	851.3	-0.4 (-0%)	Small Cap	6,229	30.8	9.6	27.7	3.3
Laurus Labs	627.4	0.6 (0.1%)	Small Cap	5,041	3.7	3.1	168.8	8
Piramal Pharma	220.2	-1.7 (-0.7%)	Small Cap	4,390	5.2	8.4	42.8	4.1
Ajanta Pharma	2,690	55.1 (2.1%)	Small Cap	4,209	71.9	19	36.7	8.4
Gland Pharma	1,445	1.8 (0.1%)	Small Cap	4,167	68.1	24.8	21.2	2.5
Natco Pharma	826.9	-0.3 (-0%)	Small Cap	3,999	104.1	34.5	7.9	2
Granules India	464.8	2.2 (0.5%)	Small Cap	3,755	13.3	11.7	34.8	3.4
Emcure Pharma	1,094.7	91.6 (9.1%)	Small Cap	3,498	8.5	4.4	118.2	6.6
JB Chem & Pharma	1,643.6	16.5 (1%)	Small Cap	3,299	40.4	16.1	40.3	7.6
Sanofi India	6,224	19 (0.3%)	Small Cap	2,851	136.2	20.8	45.6	16.6

Shows rows:

Prev 1 2 3 4 5 Next

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	36.84	54.92	67.67	76.04	121.70	126.83	154.28	348.67	207.01	131.37
Operating Expenses ⓘ	33.73	50.19	60.90	68.54	109.87	114.15	138.94	283.12	195.35	121.81
Manufacturing Costs	0	0	4.24	5.20	7.55	8.95	10.47	14.76	12.12	6.40
Material Costs	26.81	40.86	47.77	52.89	87.84	88.97	103.96	230.01	146.90	87.20
Employee Cost	2.37	3.47	4.12	5.64	6.39	7.24	14.35	18.32	20.27	15.90
Other Costs ⓘ	4.55	5.87	4.77	4.81	8.09	8.99	10.16	20.03	16.05	12.31
Operating Profit ⓘ	3.11	4.73	6.77	7.50	11.83	12.68	15.33	65.54	11.66	9.55
Operating Profit Margin (%)	8.4%	8.6%	10.0%	9.9%	9.7%	10.0%	9.9%	18.8%	5.6%	7.3%
Other Income ⓘ	0.09	0.21	0.25	0.69	0.23	0.42	0.75	0.95	9.84	0.84
Interest ⓘ	1.66	1.66	2.04	2.04	2.83	3.46	3.98	8.31	10.92	9.77
Depreciation ⓘ	0.95	1.06	1.17	1.19	1.12	1.23	2.24	5.12	8.52	7.75
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	-1.74
Profit Before Tax ⓘ	0.60	2.22	3.81	4.95	8.11	8.41	9.86	53.06	2.07	-8.87
Tax ⓘ	0.20	0.57	0.99	1.23	2.46	2.31	2.61	13.35	2.73	-0.22
Profit After Tax	0.40	1.65	2.82	3.72	5.65	6.10	7.25	39.71	-0.66	-8.65
PAT Margin (%)	1.1%	3.0%	4.2%	4.9%	4.6%	4.8%	4.7%	11.4%	-0.3%	-6.6%
Adjusted EPS (₹)	0.4	1.8	3.1	2.9	4.4	4.7	5.6	30.7	-0.5	-6.6
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	3%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	3.12	4.77	7.49	23.17	28.77	34.56	41.36	83.48	85.54	77.07
Share Capital ⓘ	3.68	3.68	3.68	5.18	5.18	5.18	5.18	10.37	13.06	13.06
Reserves ⓘ	-0.57	1.09	3.81	17.99	23.58	29.37	36.17	73.11	72.48	64.02
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	10.14	11.77	11.58	14.08	18.69	18.17	39.21	53.59	49.92	52.25
Long Term Debt	8.11	6.81	4.96	7.68	6.28	5.25	5.93	12.01	10.06	6.97
Short Term Debt	2.03	4.96	6.61	6.40	12.41	12.92	33.28	41.59	39.85	45.28
Trade Payables	9.72	15.08	21.39	22.32	21.81	25.79	45.24	66.27	61.95	58.18
Others Liabilities ⓘ	2.82	3.87	6.38	8.60	11.62	15.56	16.03	65.34	55.11	29.93
Total Liabilities ⓘ	25.80	35.49	46.84	68.17	80.90	94.08	141.83	268.68	252.51	217.43
Fixed Assets
Gross Block	15.88	17.18	18.30	31.56	32.41	33.96	37.54	103.07	107.94	85.39
Accumulated Depreciation	7.10	8.16	9.33	10.52	11.65	12.79	15.65	20.75	29.26	32.05
Net Fixed Assetsⓘ	8.78	9.02	8.97	21.04	20.76	21.17	21.89	82.32	78.68	53.35
CWIP ⓘ	0	0	0	0	0	0	0.40	0	0	0
Investmentsⓘ	0.02	0.02	0.02	0.02	0.02	0.02	0.02	3.52	3.52	3.52
Inventories	6.18	5.24	5.84	7.74	6.54	10	19.26	29.17	37.39	34.24
Trade Receivables	6.28	16.38	25.56	32.15	41.75	46.06	58.78	98.99	78.11	69.27
Cash Equivalents	0.47	1.03	0.91	1.48	4.37	3.60	0.11	6.59	6.05	5.50
Others Assetsⓘ	4.08	3.80	5.54	5.73	7.46	13.22	41.36	48.10	48.75	51.55
Total Assets ⓘ	25.80	35.49	46.84	68.17	80.90	94.08	141.83	268.68	252.51	217.43

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	3.13	1.86	4.51	0.88	7.46	4.83	-11.18	27.39	26.01	-13.13
PBT ⓘ	0.60	2.22	2.82	3.72	8.11	8.41	9.86	53.06	2.07	-8.87
Adjustment ⓘ	2.58	2.67	3.69	4	3.40	4.10	5.87	14.83	18.34	17.46
Changes in Working Capital ⓘ	0.03	-2.61	-1.13	-5.81	-1.68	-5.02	-26.29	-39.92	8.96	-8.32
Tax Paid ⓘ	-0.08	-0.42	-0.87	-1.03	-2.37	-2.65	-0.63	-0.58	-3.36	-13.40
Cash Flow From Investing Activity ⓘ	-2.32	-2.92	-1.15	-13.40	-0.77	-1.66	-7.79	-42.50	-9.35	20.02
Capex	-0.70	-1.31	-1.12	-13.26	-0.84	-1.64	-4.07	-39.35	-10.43	19.06
Net Investments	0	0	0	0	0	0	-3.92	-3.43	0.45	0.44
Others ⓘ	-1.61	-1.61	-0.03	-0.14	0.07	-0.01	0.20	0.28	0.63	0.52
Cash Flow From Financing Activityⓘ	-0.89	1.63	-3.48	13.10	-3.80	-3.95	18.81	15.29	-16.75	-7
Net Proceeds from Shares ⓘ	0	0	0	12.01	0	0	0	0	2	0
Net Proceeds from Borrowing ⓘ	-1.66	-1.30	-1.85	2.72	-1.41	-1.03	2.34	10.40	-6.51	-3.09
Interest Paid ⓘ	0	0	-1.53	-1.58	-2.34	-2.87	-3.58	-6.60	-10.19	-8.95
Dividend Paid ⓘ	0	0	0	0	0	0	0	-1.04	0	0
Others ⓘ	0.77	2.93	-0.10	-0.05	-0.05	-0.05	20.05	12.52	-2.04	5.04
Net Cash Flow ⓘ	-0.08	0.56	-0.12	0.57	2.89	-0.77	-0.16	0.17	-0.08	-0.12

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	13.86	41.97	46.06	24.29	21.75	19.25	19.1	63.62	-0.78	-10.64
ROCE (%)	15.15	23.36	29.66	22.23	23.66	22.39	19.9	53.78	9.18	0.66
Asset Turnover Ratio	1.45	1.79	1.64	1.32	1.63	1.45	1.31	1.7	0.79	0.56
PAT to CFO Conversion(x)	7.83	1.13	1.6	0.24	1.32	0.79	-1.54	0.69	N/A	N/A
Working Capital Days
Receivable Days	68	75	113	138	111	126	124	83	156	205
Inventory Days	60	38	30	33	21	24	35	25	59	100
Payable Days	129	111	139	151	92	98	125	88	159	251

ANG Lifesciences India Ltd Stock News

View All News

ANG Lifesciences India Ltd FAQs

What is the share price of ANG Lifesciences?

Company share prices are keep on changing according to the market conditions. The closing price of ANG Lifesciences on 17-Apr-2025 16:01 is ₹27.89.

What is the market cap of ANG Lifesciences?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 17-Apr-2025 16:01 the market cap of ANG Lifesciences stood at ₹36.05.